ProQuest Investments
Founded in 1998, ProQuest Investments is a healthcare venture capital firm with over $875 million under management. Based primarily in Princeton, New Jersey, with additional offices in San Diego and Montreal, the company invests in healthcare companies seeking financings ranging from seed to late-stage. Their portfolio spans diverse therapeutic categories, including oncology, pain, and infectious disease.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Quebec
Biosyntech
Venture Round in 2009
Biosyntech is a Canadian biotechnology company based in Laval, incorporated in 1994. It specializes in developing biotherapeutic thermogels for tissue repair and therapeutic agent delivery. The company's technology platform, BST-Gel, utilizes chitosan, a natural biopolymer derived from crustacean shells, to create hydrogels. Biosyntech's lead products include BST-CarGel for cartilage repair, BST-DermOn for wound healing, and BST-InPod for treating chronic pain due to plantar fat pad atrophy in the heel and forefoot. The company has collaborated with Nicholas Piramal India Ltd. on clinical studies for BST-InPod. Additionally, Biosyntech develops products like BST-Ossifil, BST-Ossifix, and BST-Disc for bone repair and intervertebral disc restoration.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.